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Abstract 
Background: The AP-2 transcription factor APTF-1 is crucially required for developmentally controlled sleep behav-
ior in Caenorhabditis elegans larvae. Its human ortholog, TFAP-2beta, causes Char disease and has also been linked 
to sleep disorders. These data suggest that AP-2 transcription factors may be highly conserved regulators of various 
types of sleep behavior. Here, we tested the idea that AP-2 controls adult sleep in Drosophila.
Results: Drosophila has one AP-2 ortholog called TfAP-2, which is essential for viability. To investigate its potential role 
in sleep behavior and neural development, we specifically downregulated TfAP-2 in the nervous system. We found 
that neuronal TfAP-2 knockdown almost completely abolished night sleep but did not affect day sleep. TfAP-2 insuf-
ficiency affected nervous system development. Conditional TfAP-2 knockdown in the adult also produced a modest 
sleep phenotype, suggesting that TfAP-2 acts both in larval as well as in differentiated neurons.
Conclusions: Thus, our results show that AP-2 transcription factors are highly conserved regulators of development 
and sleep.
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Background
Sleep is an important part of human life and it is criti-
cal for learning performance and physical as well as 
mental well-being. Sleep disorders are widespread in 
modern societies but often the underlying mechanisms 
are not understood [1]. Sleep is controlled by the nerv-
ous system. Crucial to the induction of sleep in mammals 
are sleep-active sleep-promoting neurons such as those 
found in the Ventral Lateral Preoptic area (VLPO). These 
neurons express GABA and neuropeptides and are active 
preferentially at the onset of sleep to actively induce sleep 
[2]. However, little is known about the control of sleep at 
the molecular level in any system.
Experimental animal models are invaluable for ana-
lyzing medically relevant problems. In the recent past, 
invertebrate models have been established to study sleep. 
The use of invertebrate models has been made possible 
because careful analysis shows that sleep, as defined by 
behavioral criteria, could be found in the different phyla 
across the animal kingdom. These behavioral criteria 
include the absence of voluntary movement, an increased 
arousal threshold, and homeostatic regulation [3].
By applying these behavioral criteria, sleep was identi-
fied in the two major invertebrate model systems, Dros-
ophila melanogaster and Caenorhabditis elegans. In C. 
elegans, quiescence behavior can be found during lar-
val development as well as in adults [4]. The larval qui-
escence is called lethargus and is under developmental 
control and always precedes each of the four molts [5]. 
Lethargus quiescence also fulfills the behavioral criteria 
that define sleep, and thus this behavior has been pro-
posed to be a sleep state [6, 7]. While initially the rela-
tionship between the various types of sleep was unclear, 
the ongoing molecular dissection of these processes sug-
gests that they are carried out by similar molecular mech-
anisms [8]. This molecular data suggests that, despite the 
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differences between the zoology of sleep in various sys-
tems, a common sleep-inducing mechanism evolved only 
once in evolution. This sleep machinery then radiated to 
give rise to the various types of sleep and different con-
texts in which sleep is employed. The common origin 
of sleep behavior enables studying the basic molecular 
mechanisms of sleep using simple animal models, which 
allows translating findings on sleep between different 
models.
In a brute-force screen for genes that control sleep 
behavior in C. elegans, the transcription factor Acti-
vator Protein 2 (AP-2) was found. Several AP-2 fam-
ily genes have been found in vertebrates. The proteins 
encoded by these are very similar and can form heter-
odimers, which may contribute to their ability to regu-
late a wide variety of target genes. Deletion of APTF-1, 
one of four AP-2 paralogs in C. elegans, completely abol-
ished locomotion quiescence. APTF-1 expressed in only 
few neurons including a single neuron that is called RIS. 
This neuron is sleep-active and sleep-promoting, and it 
expresses GABA and neuropeptides. APTF-1 is required 
for expression of inhibitory neuropeptides in RIS [9–11]. 
Thus, the RIS neuron in C. elegans appears to be similar 
to sleep-active neurons in mammals.
In humans, Char syndrome is found in patients that 
carry hemizygous loss-of-function mutations in TFAP-
2beta, one of five AP-2 orthologs found in mammals 
[12, 13]. Whereas the loss of both alleles of TFAP-2beta 
is lethal, the loss of one of the alleles causes a haploin-
sufficiency phenotype that is characterized by abnormal 
limb, face, and heart development. These include a flat 
face with wide-set eyes, a patent ductus arteriosus, and 
a shortened or absent middle segment of the fifth finger. 
Sleep abnormalities in two families with Char syndrome 
have been reported, manifested either as sleepwalking or 
insomnia [14]. However, the sample size of the study was 
low. Also, the sleep phenotypes were not verified using 
sleep polysomnograms, making it difficult to understand 
the nature of the sleep problems in these patients. This 
is especially concerning as insomnia and sleepwalking 
are typically not linked. Maybe because the link between 
AP-2 and sleep was too weak, this initial observation was 
not followed in further publications.
The results from C. elegans on RIS support the view 
that sleep neurons are conserved regulators of sleep. 
If the role of AP-2 transcription factors in sleep is con-
served, it will provide an entry point into studying sleep 
control in various systems. Also this would provide 
evidence for a common evolutionary origin of sleep 
neurons.
Here, we tested this idea directly by analyzing the role 
of AP-2 in sleep in Drosophila. In Drosophila, sleep has 
been mostly studied in adult flies. In this system, sleep 
behavior is under strong circadian control and is conven-
iently defined as an absence of movement that lasts more 
than 5  min. Flies show sleep behavior both during the 
middle of the day, called a siesta, and a more prominent 
sleep behavior during the night [15, 16].
Drosophila AP-2 displays a great degree of similarity 
with AP-2 proteins from other organisms. The DNA-
binding domain is the most conserved part of the protein, 
and Drosophila AP-2 binds to the same DNA sequence 
as its mammalian counterparts [17]. Similarly to mouse 
AP-2 mutants and human patients with Char syndrome, 
Drosophila AP-2 mutants are defective in joint develop-
ment, where AP-2 acts in regulatory pathways that coor-
dinate limb-growth with development of local and higher 
order aspects of limb-specific neural circuitry [18, 19]. 
Based on analyses of mouse, frog and chick AP-2 family 
members, vertebrate AP-2 transcription factors appear to 
play conserved roles in similar developmental contexts. 
The expression domains of AP-2 that seem most evi-
dently conserved between fly and vertebrates are those 
in the nervous system, head and limbs. Considering con-
served functions of vertebrate and invertebrate AP-2, we 
tested whether Drosophila AP-2 regulates sleep analo-
gously to its C. elegans counterpart. We downregulated 
AP-2 in the Drosophila nervous system and found that 
AP-2 is specifically required for night sleep, and despite 
its role in development of the nervous system, it is also 
involved in the adult brain for sleep control.
Methods
Fly strains and genetics
RNA interference mutants TfAP-2RNAi (v41130 and 
v101552) were obtained from VDRC. Efficiency of 
TfAP-2 downregulation was tested by RT-qPCR and 
the mutant TfAP-2RNAi (v101552), which had stronger 
TfAP-2 downregulation (about 60%), was used in all the 
experiments. To downregulate TfAP-2 specifically in 
the nervous system and in subsets of neurons, the fol-
lowing driver lines (obtained from BDSC) were used: 
elavGal4 (pan-neuronal driver), elavGal4;;UAS-Dcr-2 
(drives expression of Dcr-2 in the nervous system), 
elavGal4;;tubGal80ts (Gal80ts restricts GAL4 expression 
when kept at 18  °C), c41Gal4 (expresses GAL4 in cen-
tral brain and optic lobes), TimGal4 (expresses GAL4 in 
the circadian rhythm pattern of the timeless gene), PDF-
Gal4 (expresses GAL4 in PDF-expressing ventrolateral 
brain neurons), 201yGal4 (drives expression in γ and α/β 
mushroom body (MB) lobes), cv-cGal4 (expresses GAL4 
in cross veinless-c expressing neurons of fan shaped body 
involved in sleep regulation), sNPFGal4 lines #49295, 
#48919, #49852 and #48880 (express GAL4 under con-
trol of sNPF regulatory sequences). sNPFGal4 (#49852) 
has expression pattern similar to sNPF antibody staining, 
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shows strong expression in the MBs and therefore was 
also used as MB-driver. To visualize the structure of all 
MB lobes, the MB-247dsRed line was used [20]. The 
UAS-CD8GFP:UAS-nLacZ line (a gift from Frank Hirth) 
was used to visualize Gal4 expression. w1118 flies, trans-
genic mutants crossed to w1118 or driver lines crossed 
to UAS-CD8GFP:UAS-nLacZ were used as controls. 
To overexpress TfAP-2 we used UAS-AP-2 transgenic 
flies (BDSC #23881) crossed to Gal4-expressing driver. 
Overexpression of TfAP-2 did not cause a sleep pheno-
type (Additional file  1: Table S2). To assay specificity of 
our newly generated anti-TfAP-2 antibodies we used an 
amorphic allele, TfAP-215 (BDSC #23721).
Drosophila sleep monitors
A video monitor was used similar as described previ-
ously [21]. Briefly, flies were kept in DAM monitor tubes 
(Trikinetics) that contained ~1  cm of cornmeal sucrose 
medium on one side and this tube side was sealed with 
paraffin wax. After filling in a single male fly, the vial was 
closed with a foam plastic plug. 30 vials were taped onto 
a frosted glass plate and were placed inside an aquarium 
(50 cm × 60 cm × 50 cm) containing a 1  l beaker filled 
with distilled water as a moisture reservoir. For imaging 
we used a webcam (Zeiss), covered with an infrared fil-
ter (Delamax, 850 nm). An infrared lamp (Abus TV6855 
LED) was placed half a meter behind the vials containing 
the flies to allow dia-illumination. A day-night cycle was 
displayed using an HL108S LED white-light floodlight 
controlled by a timer to provide a 12  h light–12  h dark 
cycle. The room was temperature-controlled to 25  °C. 
Fly activity was monitored and sleep parameters were 
extracted using Pysolo software. For experiments using 
infrared beam crossing, a standard protocol described 
by Rosato and Kyriacou [22] was used. Sleep parameters 
were analyzed using Microsoft Excel based counting 
macro [23].
Immunohistochemistry
Brains were dissected in PBS and fixed in 4% formalde-
hyde (Polysciences, Inc.), adult and pupal for 30  min, 
larval for 15  min. Staining was performed as described 
[24]. The TfAP-2 antibody was commercially produced 
(Davids Biotechnolgie) as described [19]. Briefly, the 
c-terminal peptide of TfAP-2, CLDKSKIDNEKK, was 
synthetized, KLH conjugated, and antisera were gen-
erated in rabbits. The antibodies were then affinity-
purified against the peptide and used in concentration 
1:500 for Western blotting on embryonic tissue lysate 
(protein separation was done on 15% SDS-PAGE) or for 
immunostaining of the brain. In addition, the following 
antibodies were used: mouse anti-Fas II 1:20 (DSHB, 
marks γ and α/β MB lobes), mouse anti-PDF 1:20, rabbit 
anti-sNPF 1:1000 (a gift from Jan-Andrianus Veenstra), 
and chicken anti-GFP 1:1000 (Abcam). Alexa 488, 568, 
or 633 goat anti-mouse, anti-rabbit, anti-chicken (1:500, 
Molecular Probes). DAPI was used to visualize nuclei.
Imaging and image analysis
Images were obtained with a confocal laser-scanning 
microscope Zeiss LSM700 and processed with Adobe 
Photoshop. Mushroom body (MB) size was measured 
from maximum intensity projection images for at least 10 
FasII stained MB lobes taken at the same magnification. 
By using ZEN 2011 software, FasII positive MB lobes 
were outlined and their area in µm2 was calculated. Data 
were presented as relative to control. The statistical sig-
nificance of the observed difference was calculated using 
a two-tailed Student’s t test. The intensity of TfAP-2 anti-
body staining in large ventral lateral neurons (l-LNv) was 
quantified by ZEN 2011 software from single section 
images taken across anti-PDF-marked cells. To calculate 
absolute intensity of TfAP-2 expression specifically in 
l-LNv neurons, the background staining (measured from 
the same size area in the neighboring non-PDF-express-
ing cells) was subtracted. To test whether AP-2 expres-
sion was downregulated in l-LNv neurons by expressing 
TfAP-2 RNAi with TimGal4 driver, we compared TfAP-2 
antibody staining intensity of TimGal4  >  TfAP-2 l-LNv 
neurons with control l-LNv neurons (TimGal4  >  GFP). 
Data were collected for at least 10 l-LNv neuronal clus-
ters. The significance of AP-2 down regulation was calcu-
lated using one-tailed Student’s t test.
RNA preparation and real time quantitative PCR
To determine the efficiency of TfAP-2 downregula-
tion in TfAP-2RNAi mutants and the effect of TfAP-2 
on other gene expression, mRNA levels quantitative 
reverse transcription PCRs (RTqPCR) were performed 
on total RNA derived from whole Drosophila bodies. 
RNA was extracted from flies using the TRIzol reagent 
(Invitrogen), followed by reverse transcription using 
the High Capacity cDNA Reverse Transcription kit 
(Applied Biosystems) following the manufacturer’s pro-
tocol. mRNA levels were tested with RpL32 or Act5c as 
an endogenous controls for the qPCR using Fast SYBR 
Green master mix on a Step One Plus 96 well system 
(Applied Systems). Following primers were applied: 
RpL32 forward AAGATGACCATCCGCCCAGC; RpL32 
reverse GTCGATACCCTTGGGCTTGC; Act5c for-
ward GTGCACCGCAAGTGCTTCTAA; Act5c reverse 
TGCTGCACTCCAAACTTCCAC; TfAP-2 forward 
ATAGCCGAAGTACAGCGTCG; TfAP-2 reverse 
CCAGCTTCTCCCTCAACAGG; sNPF forward: 
CACACCATCTTCGAGCTGAATAA; sNPF reverse 
TTTTCAAACATTTCCATCGT. All reactions were run 
Page 4 of 11Kucherenko et al. BMC Neurosci  (2016) 17:72 
in triplicate. The threshold cycle (CT) is defined as the 
fractional cycle number at which the fluorescence passes 
the fixed threshold. The ΔCT value was determined by 
subtracting the average RpL32 or Act5c CT values from 
the AP-2 and sNPF CT values. The ΔΔCT value was calcu-
lated by subtracting the ΔCT of the control sample from 
the ΔCT of the suspect sample (TfAP-2RNAi mutant). The 
relative amount of mRNA was then determined using the 
expression 2−Ct. Significant changes in mRNA levels 
were calculated using two-tailed Student’s t test.
Phylogenetic tree generation
The multiple alignment and phylogenetic tree were 
computed with Clustal W phylogeny by pasting in the 
following sequences [25]: tfap-2alpha(Homo sapiens) 
accession EAW55251, tfap-2epsilon(H. sapiens) accession 
NP_848643, tfap-2beta(H. sapiens) accession CAA64990, 
tfap-2delta(H. sapiens) accession NP_758438, tfap-
2gamma(H. sapiens) accession NP_003213, aptf-1(C. 
elegans) accession NP_495300, aptf-2(C. elegans) 
accession NP_001255740, aptf-3(C. elegans) accession 
NP_495819, aptf-4(C. elegans) accession NP_495818, 
tfap-2(Nematostella vectensis) accession XP_001633944, 
tfap-2(Trichoplax adhaerens) accession XP_002114137, 
tfap-2(D. melanogaster) accession NP_649336.
Results
TfAP‑2 is required for night sleep
AP-2 transcription factors are highly conserved among 
metazoans. The Drosophila genome contains only one 
AP-2 gene that is called TfAP-2 (Fig.  1A) [12]. Ubiq-
uitous early knockdown of this gene is lethal at the lar-
val or pupal stage, and hypomorphic loss-of-function 
mutation affects limb and brain development [19]. To 
test for sleep phenotypes, we generated viable mutants 
using RNAi to knock down TfAP-2 specifically in the 
nervous system [26, 27]. We followed the sleep behav-
ior of the flies using established sleep monitor systems. 
For the RNAi experiments, we used transgenic flies that 
expressed a double-stranded RNAi hairpin construct 
that targets TfAP-2 under the control of the upstream 
activating sequence (UAS). To drive expression in the 
entire nervous system, we used the elavGal4 driver. For 
an initial experiment we also included Dcr-2 expression, 
which can increase the efficiency of RNAi [28]. We used 
two independent RNAi constructs, TfAP-2RNAi(v41130) 
and TfAP-2RNAi(v101552) [29]. To monitor sleep, we used 
a video-based system and analyzed the behavior of male 
flies during a 12 h light–12 h dark cycle [21]. As controls, 
we used the parental strains. Control flies showed some 
sleep during the middle of the day, and substantial sleep 
during the night (Fig. 1B). However, TfAP-2RNAi reduced 
night sleep specifically. Whereas there was a modest 
reduction for TfAP-2RNAi(v41130), night sleep was almost 
completely abolished in TfAP-2RNAi(v101552) flies, with 
some individuals completely lacking any detectable night 
sleep (Fig. 1B, C; Additional file 1: Figure S1). To measure 
the knockout strength of the RNAi, we performed quan-
titative real-time PCR for TfAP-2 mRNA on TfAP-2RNAi 
flies. mRNA levels for TfAP-2 were reduced by 22% in 
TfAP-2RNAi(v41130) and by 58% in TfAP-2RNAi(v101552) (Addi-
tional file 1: Figure S2, Table S1). Even though Dcr-2 has 
been found to be useful for increasing the RNAi, it can 
also increase off target effects [29]. Thus, we repeated the 
sleep measurements without Dcr-2 over-expression and 
did not use Dcr-2 for any further experiments. We also 
switched to a sleep monitor system that detects locomo-
tion based on infrared-beam arrays, which was easier to 
use in comparison to the video monitor [15, 16, 30]. This 
experiment reproduced the sleep phenotype for neural 
TfAP-2RNAi. However, the observed phenotypes appeared 
slightly weaker when compared with Dcr-2 expression 
(Fig.  1D, E). Thus, TfAP-2 is specifically required for 
night sleep, but not for siesta sleep. The sleep phenotype 
strength correlated with the knockout strength for the 
two different RNAi constructs, suggesting that the effects 
are indeed caused by TfAP-2 knockdown. Like C. elegans 
aptf-1, Drosophila TfAP-2 acts in the nervous system to 
control sleep.
TfAP‑2 is expressed in the nervous system
Because TfAP-2 was required in the nervous system to 
control sleep, we wanted to know more about the expres-
sion of this transcription factor. We raised an antibody 
against TfAP-2 and investigated the expression pat-
tern using immunostaining in both the larval and adult 
nervous system. As published previously, we observed a 
strong AP-2 staining in the leg discs implying specific-
ity of the newly generated antibody (Additional file  1: 
Figure S3 A, B). To further test the specificity of newly 
generated antibody we stained individuals carrying the 
amorphic allele TfAP-215 and observed that in compari-
son to control (TfAP-215/TM6,Tb), TfAP-215 homozygous 
mutant brains did not express TfAP-2 (Additional file 1: 
Figure S3 C, D). In the 3rd instar larvae, we found strong 
expression in a subset of neurons in the central brain 
region, but also in the medulla and lamina (Fig. 2A). The 
expression partly overlapped with Tim-expressing neu-
rons (Fig.  2B). In adult brains, the expression levels of 
AP-2 appeared much lower compared with larval brains. 
Importantly, we found TfAP-2 protein to be expressed 
in sleep-related sNPF-, Tim- and PDF-expressing neu-
rons (Fig. 2C, D) and by driving TfAP-2RNAi with Tim-
Gal4 driver we were able to significantly reduce TfAP-2 
expression specifically in l-LNv neurons measured by the 
intensity of TfAP-2 antibody staining (Fig.  2D–F) and 
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Fig. 1 Neuronal TfAP-2 is required for night sleep. A TfAP-2 is a well-conserved transcription factor present in most multicellular organisms of the 
animal kingdom. The multiple alignment and phylogenetic tree were computed with Clustal W phylogeny [25]. B The sleep profile of adult flies was 
generated using a video monitoring protocol and extracted by PySolo. Expression of Dcr-2 and TfAP-2RNAi were induced in neurons throughout the 
life history of these flies. C Quantification of sleep in Dcr-2 and TfAP-2RNAi flied. D Sleep profile of flies was recorded using Trikinetics infra-red beam 
crossing and processed by a counting macro. Neuronal knockdown of TfAP-2 results in drastic reduction of night sleep in the presence of Dcr-2. The 
phenotype is weaker when knockdown is achieved without exogenous Dcr-2. UAS-TfAP-2 RNAi (v101552) strain was used for knockdown of TfAP-2 
in these experiments. E Quantification of sleep parameters measured in d. ***p < 0.0001 Student t test. *p < 0.05 determined by one way ANOVA, 
Dunnet post hoc test
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Fig. 2 TfAP-2 is expressed in larval and adult Drosophila brain. Antibodies against TfAP-2 were used to reveal the TfAP-2 expression pattern in devel-
oping larval (A, B) and adult (C) Drosophila brains. A c41Gal4 driver expressing membrane bound GFP was used to mark contour and the central 
brain regions. In 3rd instar larvae TfAP-2 was found to have strong expression in the subsets of neurons located in the central brain (yellow arrows), 
medulla (parenthesis) and lamina (blue arrows) regions. B In larval brain TfAP-2 is also expressed in some of TimGal4 > CD8GFP expressing neurons 
(arrows). C In adult brain TfAP-2 protein can be found in ventral lateral neurons marked with sNPF > CD8GFP (blue arrows) and anti-PDF staining (yel-
low arrows). D TfAP-2 expression in l-LNv neurons marked with TimGal4 > CD8GFP and anti-PDF in adult brain. E TfAP-2 expression in l-LNv neurons 
marked with anti-PDF in TimGal4 > TfAP-2RNAi mutant adult brain. F Bar graph shows relative intensity of TfAP-2 antibody staining in PDF-express-
ing neurons for TimGal4 > CD8GFP (control) and TimGal4 > TfAP-2RNAi animals. Antibody staining intensity (Mean ± Average deviation) is 1 ± 0.33 
(n = 27) for control, and 0.51 ± 0.17 (n = 10) for TfAP-2RNAi. n, number of l-LNv neuronal clusters. Statistical significance of TfAP-2 downregulation 
was calculated by Student t test, p = 0.00023
Page 7 of 11Kucherenko et al. BMC Neurosci  (2016) 17:72 
RTqPCR (Additional file  1: Table S1). Thus, TfAP-2 is 
expressed in larval and adult neurons and the intensity of 
AP-2 expression is decreased during adulthood in com-
parison to pre-adult stages.
TfAP‑2 is required for nervous system development
The strong expression of TfAP-2 in larvae suggested 
that this transcription factor plays a role in the devel-
opment of the nervous system. Thus, we investigated 
whether neuron-specific downregulation of TfAP-2 
affects brain development, which would result in the 
appearance of abnormal structures in the adult brain. 
We focused especially on the adult mushroom body 
(MB) and sNPF-expressing neurons, as these compart-
ments have been implicated in sleep control [31–33]. 
We found that the mushroom body morphology was 
severely affected. Axonal projections of α/β MB lobes 
marked by FasII expression were slimmer or dis-
rupted, which affected the average volume of MB lobes 
(Fig.  3A–D). Following this observation we marked 
MB in larval (with 201y Gal4  >  GFP) and pupal (with 
MB247dsRed) brains and analyzed TfAP-2 expression 
pattern. TfAP-2 protein was expressed in mushroom 
body neuroblasts during the pupal stage (the time point 
of α/β MB lobes formation), but not in larvae (Fig. 3E, 
F). Thus, consistent with previous findings [19], knock-
down of TfAP-2 influenced MB neural morphogenesis. 
Since MB neurons express plenty of short neuropeptide 
F (sNPF, Fig.  3G), which has been shown to regulate 
sleep in Drosophila [33], we evaluated sNPF expression 
by detecting its protein and mRNA levels in control 
and TfAP-2 mutant (Fig. 3G–J; Additional file 1: Table 
S1). We did not observe significant effect of TfAP-2 
downregulation on sNPF expression suggesting that 
TfAP-2 controls sleep independently of sNPF. Based 
on the TfAP-2 expression pattern, we hypothesized 
that TfAP-2 acts in either MB-, sNPF-, Tim- or PDF-
expressing neurons. We thus used these tissue-specific 
Gal4 lines as well as cv-cGal4 driver, which is expressed 
in known sleep-controlling crossveinless-c neurons [34] 
to downregulate TfAP-2 and to monitor sleep behav-
ior. As GABAergic neurons play a role in sleep control, 
we also tested the gad-Gal4 driver [35]. A recent study 
reported that TfAP-2 regulates Drosophila aggres-
sion behavior by acting in octopaminergic neurons 
[26, 27, 36]. In addition, it has been previously shown 
that octopamine regulates sleep in Drosophila and we 
hence also tested tdc-Gal4 [37]. None of these experi-
ments gave a sleep phenotype, suggesting that either 
the knockdown strength was not strong enough or that 
TfAP-2 is required in other neurons that are yet to be 
identified or acts redundantly in several neuron types 
(Additional file 1: Table S2).
TfAP‑2 is required for sleep also in the adult brain
While AP-2 appears to have a role in development, it 
may exert its function in sleep not only through a role in 
development, but may rather work in differentiated neu-
rons. To test this idea, we knocked down TfAP-2 specifi-
cally in adults and tested for sleep phenotypes. For this 
experiment, we used a temperature-sensitive suppres-
sor of Gal4, Gal80ts, which was expressed ubiquitously. 
Under normal growth conditions Gal80ts represses the 
expression of the RNAi construct but can be inactivated 
by increasing the temperature to 30  °C. We grew larvae 
under permissive temperatures and then knocked down 
TfAP-2 specifically in adults by shifting the adults to the 
higher temperature. We found that adult-specific neural 
TfAP-2RNAi also caused a reduction in night sleep. How-
ever, the reduction of sleep was much smaller compared 
with permanently active neural TfAP-2 downregulation 
(Fig. 4A, B). This suggests that TfAP-2 is required during 
neural development but also plays a role in differentiated 
neurons of the adult. Because TfAP-2 expression in adults 
is very low, the neurons through which TfAP-2 acts in 
adults to control sleep are difficult to identify with avail-
able immunohistochemistry approaches. Thus, TfAP-2 is 
required in neurons that remain to be identified. 
Discussion
Both C. elegans and Drosophila are well-established 
powerhouses of molecular biology, and sleep research in 
these systems is highly attractive. Both Drosophila and C. 
elegans belong to the group of molting animals (Ecdyso-
zoa) [38]. The nervous system of Drosophila is more 
complex and contains approximately 100.000 neurons 
compared with 302 neurons and a mapped connectiv-
ity in C. elegans [39]. Thus, while C. elegans is easier to 
use for circuit analysis, Drosophila can be used to study 
more complex aspects of brain regulation. In Drosophila, 
sleep behavior is light dependent and coupled to a clear 
day-night cycle. In C. elegans, genes homologous to the 
genes that control circadian behavior in other organ-
isms also control sleep behavior. However, the periodicity 
in C. elegans is shorter and the rhythm is not entrained 
by light [40, 41]. Whereas the Drosophila sleep system 
can be used to study the control by the day-night cycle, 
the developmental sleep system of C. elegans facilitates 
genetic analyses. Finally, the transparency of C. elegans 
also allows non-invasive functional brain imaging [42]. 
Thus, both C. elegans and Drosophila have their unique 
strengths, which nicely complement each other. These 
models have the capacity to ultimately solve molecular 
mechanisms underlying sleep control, and because of the 
common evolutionary origin of sleep, these findings may 
be translatable to the mammalian system and thus may 
help understand the causes of human sleep disorders.
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In Drosophila, transcription factor TfAP-2 is not only 
a potent regulator of developmental processes, but it 
is also expressed in the adult brain and controls multi-
ple behavioral processes (Fig.  4C). Here we show that 
TfAP-2 is required in neurons for adult sleep in Dros-
ophila (Fig.  4C). Thus, AP-2 transcription factors are 
conserved regulators of sleep. Generally, transcription 
factors have been crucial in resolving evolutionary rela-
tionships. A good example is PAX6, which is required for 
eye development in various species. This led to the view 
that all eyes, despite their differences in different spe-
cies, have evolved from an ancestral prototypic eye [43]. 
Fig. 4 TfAP-2 is required in the adult brain for effective night sleep. A Pan-neuronal knockdown of TfAP-2 in adult neurons reduces night sleep. In 
order to restrict knockdown of TfAP-2 in neurons only during adulthood a temperature-sensitive Gal80 allele was used. These flies were reared at 
permissive temperature of 18 °C and then switched to restrictive temperature of 30 °C after adult emergence. The sleep assay was also conducted 
at 30 °C. UAS-TfAP-2 RNAi (v101552) strain was used for knockdown of TfAP-2 in these experiments. B Total sleep, relative day sleep and relative night 
sleep of the parental controls and mutant flies. C TfAP-2 functions in larval and adult Drosophila brain. *p < 0.05 determined by one way ANOVA, 
Dunnet post hoc test
(See figure on previous page.) 
Fig. 3 TfAP-2 downregulation affects brain development. Downregulation of Drosophila TfAP-2 with pan-neuronal driver elavGal4 caused signifi-
cant mushroom body developmental defects. In comparison to Control (A) TfAP-2 mutant brains (elav > AP-2RNAi v101552) had slimmer (B, arrows) 
and/or disrupted (C, arrows) axonal projections of MB neurons visualized by anti-FasII staining (a marker for γ and α/β MB lobes). D The bar graph 
shows relative size of α/β MB lobes. Analysis of TfAP-2 protein expression in larval (E) and pupal (F) developing brains revealed no significant TfAP-2 
expression in MB neuronal cell bodies (E–E″ marked with γ lobe marker 201Gal4 > CD8GFP) and (F–F″ marked with γ, α‘/β‘and α/β MB lobes marker 
MB247dsRed) but considerable TfAP-2 expression in pupal MB neuroblasts (F, arrows). MB calyces are outlined. (G, H) TfAP-2 reduction with elavGal4 
driver did not have prominent effect on sNPF protein localization in the MBs and sNPF neuron-specific downregulation of TfAP-2 (I, J) did not cause 
significant reduction in sNPF mRNA levels
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Similarly, the conserved role of AP-2 in sleep control 
provides strong support for the view that larval sleep 
behavior in C. elegans and adult night sleep in Drosoph-
ila share a common evolutionary origin. Besides a strong 
role of TfAP-2 in development, this transcription factor 
appears to also play a role in sleep in differentiated adult 
neurons. Unfortunately, the weak expression in the adult 
brain compared with the strong expression during devel-
opment has impaired a straightforward identification of 
the neurons in which TfAP-2 acts in sleep control. More 
sensitive localization analyses combined with cell-spe-
cific RNAi may solve this problem in the future.
Conclusions
Sleep is found in all animals that have a nervous system 
but little is known about the evolutionary origins of sleep. 
The transcription factor AP2 is linked to Char disease and 
insomnia in humans, and is required for sleep neuron 
function in C. elegans. Here we show that AP2 is crucially 
required for night sleep in Drosophila. Despite regulating 
larval development, AP2 is also required in the adult brain 
for sleep control. Thus, our work shows that AP2 tran-
scription factors are conserved regulators of sleep and this 
work thus provides strong support for a common evolu-
tionary origin of sleep-controlling mechanism. We estab-
lish a system in which sleeping disorders associated with 
Char disease can be studied in a highly accessible system. 
Because Drosophila and C. elegans are established model 
systems for the molecular dissection of biological pro-
cesses, it should be possible to solve the molecular role of 
AP-2 in these systems. Ultimately, further understanding 
how AP-2 works in sleep control may shed light on sleep 
disorders such as those found in Char syndrome.
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